Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Assets ₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr₹6,425 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,881 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Assets
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr
Mar2020₹6,425 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr
4.42
Mar2020 ₹6,425 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses